Is Olema Pharmaceuticals, Inc. (OLMA) a Buy, Sell, or Hold?
NASDAQ : OLMA
Olema Pharmaceuticals, Inc. — Institutional Ownership
$11.28 USD
-$0.17 (-1.48%)
- Volume
- 732.58K
- Average Volume
- 1.45M
- Market Capitalization
- $985.28M
- P/E Ratio
- -5.58
- Dividend Yield
- 0.00%
- Price Target
- $38.00
- Year High
- $36.26
- Year Low
- $4.47
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.88
Institutional Ownership Summary
Institutional Ownership %
1.04%
Investors Holding
25
change: -194 | last: 219
Increased Positions
11
change: -109 | last: 120
Reduced Positions
6
change: -47 | last: 53
New Positions
2
change: -46 | last: 48
Sold Positions
177
change: 127 | last: 50
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -24.0272 | last: 0.2403
Total Invested
13.41M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | JANUS HENDERSON GROUP PLC | 7.11M | 8.20% |
| 2026-05-15 | Bain Capital Life Sciences Opportunities IV, L.P. | 7.47M | 8.15% |
| 2026-03-20 | Invus Public Equities, L.P. | 3.9M | 4.50% |
| 2026-03-06 | FMR LLC | 10M | 12.50% |
| 2026-02-17 | JANUS HENDERSON GROUP PLC | 6.71M | 8.40% |
| 2026-02-17 | Bain Capital Life Sciences Opportunities IV, L.P. | 8.51M | 9.99% |
| 2026-02-13 | Deep Track Capital, LP | - | 0.00% |
| 2026-02-05 | FMR LLC | 5.02M | 6.30% |
| 2025-11-14 | JANUS HENDERSON GROUP PLC | 3.59M | 5.20% |
| 2025-05-15 | Deep Track Capital, LP | 3.44M | 5.04% |
| 2025-05-15 | Bain Capital Life Sciences Opportunities IV, L.P. | 6.84M | 9.99% |
| 2025-05-15 | Point72 Asset Management, L.P. | 1.54M | 2.30% |
| 2025-05-13 | Logos GP LLC | 2.51M | 3.70% |
| 2025-05-13 | Arsani William | 3.21M | 4.70% |
| 2025-05-13 | Logos Global Management LP | 3.21M | 4.70% |
| 2025-05-13 | Logos Global Management GP LLC | 3.21M | 4.70% |
| 2025-05-13 | Logos Opportunities GP LLC | 708.11K | 1.00% |
| 2025-05-13 | Graham Walmsley | 3.21M | 4.70% |
| 2025-02-14 | Paradigm BioCapital Advisors LP | 7.43M | 9.99% |
| 2025-01-13 | Bain Capital Life Sciences Opportunities IV, L.P. | 7.1M | 9.99% |
| 2024-12-11 | Bain Capital Life Sciences Opportunities IV, L.P. | 7.47M | 9.99% |
| 2024-12-11 | Bain Capital Life Sciences Opportunities IV, L.P. | 7.47M | 9.99% |
| 2024-06-14 | Point72 Asset Management, L.P. | 3.23M | 5.70% |
| 2024-06-14 | Point72 Capital Advisors, Inc. | 3.23M | 5.70% |
| 2024-06-14 | Steven A. Cohen | 3.23M | 5.70% |
| 2024-06-14 | Point72 Asset Management, L.P. | 3.23M | 5.70% |
| 2024-06-14 | Point72 Capital Advisors, Inc. | 3.23M | 5.70% |
| 2024-06-14 | Steven A. Cohen | 3.23M | 5.70% |
| 2024-03-22 | David Kroin | 3.04M | 5.44% |
| 2024-03-22 | Deep Track Capital, LP | 3.04M | 5.44% |
| 2024-03-22 | Deep Track Biotechnology Master Fund, Ltd. | 3.04M | 5.44% |
| 2024-03-22 | Deep Track Capital, LP | 3.04M | 5.44% |
| 2024-03-22 | Deep Track Biotechnology Master Fund, Ltd. | 3.04M | 5.44% |
| 2024-03-22 | David Kroin | 3.04M | 5.44% |
| 2024-01-29 | (1) BlackRock, Inc. | 3.26M | 6.00% |
| 2023-09-13 | Senai Asefaw, M.D. | 7.8M | 14.30% |
| 2023-09-13 | Paradigm BioCapital Advisors LP | 7.8M | 14.30% |
| 2023-09-13 | Paradigm BioCapital International Fund Ltd. | 6.49M | 11.90% |
| 2023-09-13 | Senai Asefaw, M.D. | 7.8M | 14.30% |
| 2023-09-13 | Paradigm BioCapital Advisors LP | 7.8M | 14.30% |
| 2023-09-13 | Paradigm BioCapital Advisors GP LLC | 7.8M | 14.30% |
| 2023-09-13 | Paradigm BioCapital International Fund Ltd. | 6.49M | 11.90% |
| 2023-09-13 | Paradigm BioCapital Advisors GP LLC | 7.8M | 14.30% |
| 2023-04-10 | Dr. Senai Asefaw | 2.52M | 6.20% |
| 2023-04-10 | Paradigm BioCapital Advisors GP LLC | 2.52M | 6.20% |
| 2023-04-10 | Paradigm BioCapital International Fund Ltd. | 1.99M | 4.90% |
| 2023-04-10 | Paradigm BioCapital Advisors LP | 2.52M | 6.20% |
| 2023-04-10 | Paradigm BioCapital International Fund Ltd. | 1.99M | 4.90% |
| 2023-04-10 | Paradigm BioCapital Advisors LP | 2.52M | 6.20% |
| 2023-04-10 | Dr. Senai Asefaw | 2.52M | 6.20% |
| 2023-04-10 | Paradigm BioCapital Advisors GP LLC | 2.52M | 6.20% |
| 2023-02-10 | Kynam Capital Management, LP | 40.42M | 5.00% |
| 2023-02-10 | Kynam Capital Management, LP | 40.42M | 5.00% |
| 2023-02-10 | Kynam Capital Management GP, LLC | 40.42M | 5.00% |
| 2023-02-10 | Yue Tang | 40.42M | 5.00% |
| 2023-02-10 | Yue Tang | 40.42M | 5.00% |
| 2023-02-10 | Kynam Capital Management GP, LLC | 40.42M | 5.00% |
| 2022-11-14 | Rajeev Shah | - | 0.00% |
| 2022-11-14 | RA Capital Management, L.P. | - | 0.00% |
| 2022-11-14 | Peter Kolchinsky | - | 0.00% |
| 2022-11-14 | Rajeev Shah | - | 0.00% |
| 2022-11-14 | RA Capital Management, L.P. | - | 0.00% |
| 2022-11-14 | Peter Kolchinsky | - | 0.00% |
| 2022-07-08 | (1) BlackRock, Inc. | 1.31M | 3.20% |
| 2022-02-11 | Fairmount Healthcare Fund II GP LLC | 2.03M | 5.00% |
| 2022-02-11 | Fairmount Funds Management LLC | 2.11M | 5.20% |
| 2022-02-11 | Fairmount Healthcare Fund II GP LLC | 2.03M | 5.00% |
| 2022-02-11 | Fairmount Funds Management LLC | 2.11M | 5.20% |
| 2022-02-11 | Fairmount Healthcare Fund GP LLC | 80997.0 | 0.20% |
| 2022-02-11 | Fairmount Healthcare Fund GP LLC | 80997.0 | 0.20% |
| 2022-02-10 | The Vanguard Group - 23-1945930 | 2.15M | 5.33% |
| 2022-02-10 | EIN #00-0000000 | 3M | 7.40% |
| 2022-02-10 | The Vanguard Group - 23-1945930 | 2.15M | 5.33% |
| 2022-02-04 | Wellington Management Group LLP | 2.02M | 5.01% |
| 2022-02-04 | Wellington Group Holdings LLP | 2.02M | 5.01% |
| 2022-02-04 | (1) BlackRock, Inc. | 2.3M | 5.70% |
| 2022-02-04 | Wellington Group Holdings LLP | 2.02M | 5.01% |
| 2022-02-04 | Wellington Investment Advisors Holdings LLP | 2.02M | 5.01% |
| 2022-02-04 | Wellington Investment Advisors Holdings LLP | 2.02M | 5.01% |
| 2022-02-04 | Wellington Management Group LLP | 2.02M | 5.01% |
| 2021-02-16 | RA Capital Management, L.P. | 2.15M | 5.40% |
| 2021-02-16 | Cormorant Private Healthcare GP II, LLC | 1.68M | 4.19% |
| 2021-02-16 | Cormorant Private Healthcare Fund II, LP | 1.68M | 4.19% |
| 2021-02-16 | Cormorant Global Healthcare GP, LLC | 871.94K | 2.17% |
| 2021-02-16 | Cormorant Global Healthcare Master Fund, LP | 871.94K | 2.17% |
| 2021-02-16 | Bihua Chen | 3.2M | 7.96% |
| 2021-02-16 | Cormorant Private Healthcare GP III, LLC | 587.87K | 1.46% |
| 2021-02-16 | Cormorant Private Healthcare GP II, LLC | 1.68M | 4.19% |
| 2021-02-16 | Cormorant Private Healthcare Fund II, LP | 1.68M | 4.19% |
| 2021-02-16 | Cormorant Global Healthcare GP, LLC | 871.94K | 2.17% |
| 2021-02-16 | Cormorant Global Healthcare Master Fund, LP | 871.94K | 2.17% |
| 2021-02-16 | Cormorant Asset Management, LP | 3.2M | 7.96% |
| 2021-02-16 | Cormorant Private Healthcare Fund III, LP | 587.87K | 1.46% |
| 2021-02-16 | Bihua Chen | 3.2M | 7.96% |
| 2021-02-16 | Cormorant Asset Management, LP | 3.2M | 7.96% |
| 2021-02-16 | Cormorant Private Healthcare GP III, LLC | 587.87K | 1.46% |
| 2021-02-16 | Cormorant Private Healthcare Fund III, LP | 587.87K | 1.46% |
| 2021-02-12 | EIN #00-0000000 | 3.64M | 9.10% |
| 2021-02-04 | Wellington Management Group LLP | 2.07M | 5.15% |
| 2021-02-04 | Wellington Group Holdings LLP | 2.07M | 5.15% |
| 2021-02-04 | Wellington Management Company LLP | 2.05M | 5.09% |
| 2021-02-04 | Wellington Management Company LLP | 2.05M | 5.09% |
| 2021-02-04 | Wellington Investment Advisors Holdings LLP | 2.07M | 5.15% |
| 2021-02-04 | Wellington Management Group LLP | 2.07M | 5.15% |
| 2021-02-04 | Wellington Group Holdings LLP | 2.07M | 5.15% |
| 2021-02-04 | Wellington Investment Advisors Holdings LLP | 2.07M | 5.15% |
| 2020-11-23 | Cormorant Private Healthcare Fund III, LP | 587.87K | 1.46% |
| 2020-11-23 | Bihua Chen | 3.27M | 8.14% |
| 2020-11-23 | Cormorant Global Healthcare Master Fund, LP | 943.4K | 2.35% |
| 2020-11-23 | Cormorant Asset Management, LP | 3.27M | 8.14% |
| 2020-11-23 | Cormorant Private Healthcare GP III, LLC | 587.87K | 1.46% |
| 2020-11-23 | Cormorant Private Healthcare GP II, LLC | 1.68M | 4.19% |
| 2020-11-23 | Cormorant Private Healthcare GP III, LLC | 587.87K | 1.46% |
| 2020-11-23 | Bihua Chen | 3.27M | 8.14% |
| 2020-11-23 | Cormorant Private Healthcare GP II, LLC | 1.68M | 4.19% |
| 2020-11-23 | Cormorant Global Healthcare Master Fund, LP | 943.4K | 2.35% |
| 2020-11-23 | Cormorant Global Healthcare GP, LLC | 943.4K | 2.35% |
| 2020-11-23 | Cormorant Private Healthcare Fund II, LP | 1.68M | 4.19% |
| 2020-11-23 | Cormorant Asset Management, LP | 3.27M | 8.14% |
| 2020-11-23 | Cormorant Global Healthcare GP, LLC | 943.4K | 2.35% |
| 2020-11-23 | Cormorant Private Healthcare Fund II, LP | 1.68M | 4.19% |
| 2020-11-23 | Cormorant Private Healthcare Fund III, LP | 587.87K | 1.46% |
| 2020-11-20 | BVF II GP LLC | 2.52M | 6.30% |
| 2020-11-20 | BIOTECHNOLOGY VALUE TRADING FUND OS, L.P. | 436.08K | 1.10% |
| 2020-11-20 | BVF PARTNERS OS LTD. | 436.08K | 1.10% |
| 2020-11-20 | BVF GP HOLDINGS LLC | 5.92M | 14.70% |
| 2020-11-20 | BVF PARTNERS L.P. | 6.66M | 16.60% |
| 2020-11-20 | MARK N. LAMPERT | 6.66M | 16.60% |
| 2020-11-20 | BIOTECHNOLOGY VALUE FUND, L.P. | 3.39M | 8.50% |
| 2020-11-20 | BVF INC. | 6.66M | 16.60% |
| 2020-11-20 | BIOTECHNOLOGY VALUE FUND, L.P. | 3.39M | 8.50% |
| 2020-11-20 | BVF PARTNERS L.P. | 6.66M | 16.60% |
| 2020-11-20 | BVF INC. | 6.66M | 16.60% |
| 2020-11-20 | Gorjan Hrustanovic | 14944.0 | 1.00% |
| 2020-11-20 | Gorjan Hrustanovic | 14944.0 | 1.00% |
| 2020-11-20 | BVF PARTNERS OS LTD. | 436.08K | 1.10% |
| 2020-11-20 | BVF GP HOLDINGS LLC | 5.92M | 14.70% |
| 2020-11-20 | MARK N. LAMPERT | 6.66M | 16.60% |
| 2020-11-20 | BIOTECHNOLOGY VALUE TRADING FUND OS, L.P. | 436.08K | 1.10% |
| 2020-11-20 | BVF I GP LLC | 3.39M | 8.50% |
| 2020-11-20 | BIOTECHNOLOGY VALUE FUND II, L.P. | 2.52M | 6.30% |
| 2020-11-20 | BVF II GP LLC | 2.52M | 6.30% |
| 2020-11-20 | BVF I GP LLC | 3.39M | 8.50% |
| 2020-11-20 | BIOTECHNOLOGY VALUE FUND II, L.P. | 2.52M | 6.30% |
OLMA Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $25.00 | 87.01M | $2.18B | $48.3M | $1.19M | $2.13B |
| 2024-12-31 | $5.83 | 58.74M | $342.47M | $139.48M | $1.43M | $204.42M |
| 2023-12-31 | $14.03 | 45.25M | $634.82M | $68.54M | $2.42M | $568.69M |
| 2022-12-31 | $2.45 | 40M | $97.99M | $23.7M | $2.56M | $76.85M |
| 2021-12-31 | $9.36 | 39.52M | $369.95M | $13.81M | $3.29M | $359.42M |
| 2020-12-31 | $48.08 | 39.31M | $1.89B | $338.55M | -$ | $1.55B |
| 2019-12-31 | $49.00 | 40.17M | $1.97B | $68000 | -$ | $1.97B |
| 2018-12-31 | $49.00 | 14.1M | $690.83M | $3.15M | -$ | $687.68M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14.91 | 102.8M | $1.53B | $52.55M | $956K | $1.48B |
| 2025-12-31 | $25.00 | 91.32M | $2.28B | $48.3M | $1.19M | $2.24B |
| 2025-09-30 | $9.79 | 85.73M | $839.32M | $35.26M | $4.48M | $808.54M |
| 2025-06-30 | $4.26 | 85.5M | $364.22M | $52.47M | $4.76M | $316.5M |
| 2025-03-31 | $3.76 | 85.43M | $321.2M | $50.64M | $1.15M | $271.71M |
| 2024-12-31 | $5.83 | 58.74M | $342.47M | $139.48M | $1.43M | $204.42M |
| 2024-09-30 | $11.94 | 57.26M | $683.72M | $35.89M | $1.7M | $649.53M |
| 2024-06-30 | $11.14 | 56.28M | $626.99M | $16.89M | $1.96M | $612.06M |
| 2024-03-31 | $10.89 | 55.57M | $605.2M | $33.72M | $2.21M | $573.69M |
| 2023-12-31 | $14.03 | 54.78M | $768.62M | $68.54M | $2.42M | $702.5M |
| 2023-09-30 | $12.35 | 44.98M | $555.47M | $117.41M | $2.62M | $440.68M |
| 2023-06-30 | $9.03 | 40.72M | $367.7M | $34.96M | $2.01M | $334.75M |